We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alibaba
BABA
$275B
| $1.3B | 3.23% |
6,047,599
-374,925
| -6% | -$78.1M |
|
|
2
AbbVie
ABBV
$472B
| $645M | 1.6% |
6,566,549
-1,596,712
| -20% | -$141M |
|
3
TSMC
TSM
$1.94T
| $642M | 1.59% |
11,302,811
-294,123
| -3% | -$15.5M |
|
4
Verizon
VZ
$201B
| $640M | 1.58% |
11,606,358
-1,912,105
| -14% | -$108M |
|
5
AT&T
T
$168B
| $598M | 1.48% |
26,188,384
-1,223,772
| -4% | -$27.9M |
|
6
Microsoft
MSFT
$2.93T
| $581M | 1.44% |
2,856,351
-90,350
| -3% | -$16.4M |
|
7
Philip Morris
PM
$313B
| $553M | 1.37% |
7,894,568
+83,026
| +1% | +$6.05M |
|
8
Amazon
AMZN
$2.45T
| $516M | 1.28% |
3,742,200
-52,720
| -1% | -$6.37M |
|
9
Dominion Energy
D
$62.2B
| $500M | 1.24% |
6,157,187
-263,010
| -4% | -$21.1M |
|
10
Chevron
CVX
$384B
| $500M | 1.24% |
5,601,169
-5,294
| -0.1% | -$474K |
|
11
United Parcel Service
UPS
$89.5B
| $497M | 1.23% |
4,467,073
+651,350
| +17% | +$65M |
|
|
12
Pfizer
PFE
$144B
| $440M | 1.09% |
14,186,638
-3,546,612
| -20% | -$120M |
|
13
ExxonMobil
XOM
$654B
| $416M | 1.03% |
9,292,935
-595,240
| -6% | -$26.7M |
|
14
Duke Energy
DUK
$101B
| $405M | 1% |
5,068,165
+75,796
| +2% | +$6.4M |
|
15
Cisco
CSCO
$451B
| $376M | 0.93% |
8,067,425
+1,066,724
| +15% | +$46.8M |
|
16
Veeva Systems
VEEV
$33.8B
| $358M | 0.89% |
1,527,998
-64,722
| -4% | -$12.8M |
|
17
Southern Company
SO
$109B
| $340M | 0.84% |
6,561,931
+1,274,233
| +24% | +$70.8M |
|
18
PepsiCo
PEP
$198B
| $340M | 0.84% |
2,569,420
+506,933
| +25% | +$66.8M |
|
19
Apple
AAPL
$5.01T
| $332M | 0.82% |
3,640,172
-202,752
| -5% | -$15.7M |
|
20
Ultragenyx Pharmaceutical
RARE
$2.5B
| $319M | 0.79% |
4,080,359
+63,599
| +2% | +$4.21M |
|
21
Merck
MRK
$326B
| $319M | 0.79% |
4,318,258
+845,384
| +24% | +$63.6M |
|
22
Coca-Cola
KO
$388B
| $284M | 0.7% |
6,359,453
-2,546,800
| -29% | -$117M |
|
23
Shopify
SHOP
$168B
| $284M | 0.7% |
2,991,000
-3,750
| -0.1% | -$260K |
|
|
LKFT
24
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $280M | 0.69% |
1,421,640
+15,097
| +1% | +$3.13M |
|
|
PPL
25
PPL Corp
PPL
$27.4B
| $276M | 0.68% |
10,675,551
-1,623,138
| -13% | -$42.2M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.